{"transactions":[{"id":1516660,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-05-15T12:36:41.000Z","date":"2024-05-13","kind":"sale","planned":false,"acquired":false,"shares":15219,"price":16.7427,"value":254807.1513,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.74 to $16.76, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-060065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024060065/ownership.xml","form_type":"4"}},{"id":1590209,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-07T21:16:46.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":4954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 4,954 vesting on March 5, 2024, and 4,957 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 4,954 vesting on March 5, 2024, and 4,957 vesting on March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":4957,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4954},"source":{"system":"sec-edgar","filing":"0000950170-24-027973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027973/ownership.xml","form_type":"4"}},{"id":1590208,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:16:46.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":1427,"price":13.5154,"value":19286.4758,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.41 to $13.61, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":15219,"source":{"system":"sec-edgar","filing":"0000950170-24-027973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027973/ownership.xml","form_type":"4"}},{"id":1590207,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:16:46.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":4954,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":16646,"source":{"system":"sec-edgar","filing":"0000950170-24-027973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027973/ownership.xml","form_type":"4"}},{"id":1600210,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-04","kind":"grant","planned":true,"acquired":true,"shares":33482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 8,370 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 8,372 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 8,370 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 8,372 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33482,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33482},"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600209,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":7117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 7,117 vesting on each of March 4, 2024 and March 4, 2025, and 7,120 vesting on March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 7,117 vesting on each of March 4, 2024 and March 4, 2025, and 7,120 vesting on March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14237,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7117},"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600208,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":false,"shares":5179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15538,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5179},"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600207,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":2042,"price":13.3733,"value":27308.2786,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11692,"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600206,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":7117,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":13734,"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600205,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":1490,"price":13.3733,"value":19926.217,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6617,"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1600204,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:39:07.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":true,"shares":5179,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":8107,"source":{"system":"sec-edgar","filing":"0000950170-24-026098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026098/ownership.xml","form_type":"4"}},{"id":1608747,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-03-01T11:40:52.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":4294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 4,294 vested on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 4,294 vested on February 28, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4294},"source":{"system":"sec-edgar","filing":"0000950170-24-023520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023520/ownership.xml","form_type":"4"}},{"id":1608746,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-01T11:40:52.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":1366,"price":13.116,"value":17916.456,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.19, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2928,"source":{"system":"sec-edgar","filing":"0000950170-24-023520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023520/ownership.xml","form_type":"4"}},{"id":1608745,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2024-03-01T11:40:52.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":true,"shares":4294,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":4294,"source":{"system":"sec-edgar","filing":"0000950170-24-023520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023520/ownership.xml","form_type":"4"}},{"id":1739973,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":91055,"kind":"person","name":"Conway Vikki L","position":1,"cik":"0001995297","reported_name":"Conway Vikki L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2023-11-16T12:36:02.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":33482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on November 15, 2023, with 8,370 vesting on each of November 15, 2024, November 15, 2025 and November 15, 2026, and 8,372 vesting on November 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on November 15, 2023, with 8,370 vesting on each of November 15, 2024, November 15, 2025 and November 15, 2026, and 8,372 vesting on November 15, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33482,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33482},"source":{"system":"sec-edgar","filing":"0001209191-23-055447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123055447/doc4.xml","form_type":"4"}}]}